adenosine vs vericiguat
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of adenosine and vericiguat. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Adenocard
Verquvo
Adenosine (Adenocard) is a medicine used to treat certain types of irregular heartbeats. It belongs to a class of drugs called antiarrhythmics.
Verquvo is a medicine that helps lower the risk of death and hospitalization from heart failure. It is for adults with long-term heart failure and a weak heart pump (ejection fraction less than 45%).
Adenosine is used to treat a very fast heart rate in the upper chambers of your heart. This condition is called supraventricular tachycardia (SVT). Adenosine helps to slow down your heart rate to a normal rhythm.
Verquvo helps to reduce the risk of dying from heart problems. It also lowers the chance of needing to go to the hospital for heart failure. This medicine is for adults who have ongoing heart failure symptoms and a weak heart pump. They also must have recently been in the hospital for heart failure or needed IV diuretics as an outpatient.
Adenosine works by slowing down the electrical signals in your heart. This helps to interrupt the fast heart rhythm and restore a normal heartbeat. It does this by acting on specific receptors in the heart tissue.
Verquvo is a soluble guanylate cyclase (sGC) stimulator. It works by helping blood vessels relax and widen. This makes it easier for your heart to pump blood.
No common side effects listed.
- • Low blood pressure
- • Anemia (low red blood cell count)
- Supraventricular Tachycardia 94
- Hypotension 86
- Cardiac Arrest 78
- Dyspnoea 74
- Pain 67
- Hypotension 106
- Death 90
- Dizziness 65
- Cardiac Failure 60
- Anaemia 35
Since this medication is administered by a healthcare provider in a monitored setting, there are no specific at-home warnings.
Verquvo can harm an unborn baby. If you are a woman who can get pregnant, you must have a pregnancy test before starting Verquvo. You must use effective birth control while taking Verquvo and for 1 month after your last dose.
It is not known if adenosine can harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if adenosine passes into breast milk, so discuss this with your doctor if you are breastfeeding.
Do not take Verquvo if you are pregnant. It can cause harm to your unborn baby. Breastfeeding is not recommended while taking Verquvo.
How to Read This adenosine vs vericiguat Comparison
adenosine is classified in the Endogenous Nucleoside (Antiarrhythmic) drug class, while vericiguat sits within the Soluble Guanylate Cyclase Stimulator class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adenosine has 399 submissions while vericiguat has 356. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adenosine or vericiguat.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.